Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
669 Durable responses with triple blockade of the DNAM-1 axis with COM701 + BMS-986207 + nivolumab in patients with platinum resistant ovarian cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
